CIHR Operating Grant: Addressing the Wider Health Impacts of COVID-19
Launched in early September, this funding opportunity seeks research proposals to address the gaps in knowledge about the wider impacts of the COVID-19 pandemic and response on the health and health care of people in Canada. Suspension/interruption of cancer screening is one of the research areas of focus.
The maximum amount per grant that can be requested for clinical trial research is $1,000,000 over 2 years; for other types of research, the maximum amount per grant is $500,000 over 2 years. Registration deadline is October 18, 2021. For more information, see https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=3548&language=E.
Learn what CanPath has to offer researchers
Are you conducting cancer, chronic disease or COVID-19 research?
The Canadian Partnership for Tomorrow’s Health, CanPath, is Canada’s largest population health study. CanPath recently released their latest video, Read More »
Are you conducting cancer, chronic disease or COVID-19 research?
The Canadian Partnership for Tomorrow’s Health, CanPath, is Canada’s largest population health study. CanPath recently released their latest video, Read More »
New Funding Opportunity from CIHR IHSPR
The Policy Research for Health System Transformation program will support 24 one-year grants ($150,000 each) that generate evidence to inform macro-level policies and support high-performing health care and public health systems in Canada. The applic... Read More »
The Policy Research for Health System Transformation program will support 24 one-year grants ($150,000 each) that generate evidence to inform macro-level policies and support high-performing health care and public health systems in Canada. The applic... Read More »